Di Bella Foundation

ABOUT US
FIND US
STATUTE
CHARTER
FINALITY

INTRO
MDB CRITERIA
ACTIVE INGREDIENTS
THERAPY
DRUGS
MONITORING
SIDE EFFECTS
LEGAL NOTES
OPERATED SYRINGE
USE OF OCTREOTIDE
PATIENT RIGHTS

MDB - CASE REPORTS
DOC - Publications
MDB - Documents

Patient Area - Statistic
DOWNLOADABLE FORMS
Patient Area - Documents
SCIENTIFIC WORKS
DBM - STATISTIC REPORTS

Communication
Scientific
Legislative


BOOKS and PUBLICATIONS
Press Review 2006
Press Review 2007
Press Review 2008
Press Review 2009
Press Review 2010
Press Review 2011
Press Review 2012
Press Review 2013
Press Review 2014
VIDEOS and MOVIES



Websites

Frequently Asked Questions

DI BELLA FOUNDATION > ACTIVE INGREDIENTS

Active

Erlotinib

Modulo variabile

Detail

Interleukin-2

Modulo variabile

Detail